Morbilliform Drug Eruption — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Morbilliform (exanthematous) drug eruption
Morbilliform (exanthematous) drug eruption is the most common adverse cutaneous drug reaction, accounting for approximately 90% of all drug eruptions. It typically develops 7-14 days after starting the causative drug (shorter on re-exposure) with a symmetrical maculopapular eruption starting on the trunk. Crucially, there is no mucosal involvement, no systemic features (fever, lymphadenopathy, organ involvement — which would suggest DRESS), and no pustulation (which would suggest AGEP). Management is drug withdrawal and symptomatic treatment with emollients and topical corticosteroids. Resolution occurs within 1-2 weeks.
Reference: BAD 2019 Drug Eruption Guidelines; NICE